1 1
COVID-19

CLIAwaived, Inc

GenBody COVID-19 Rapid Antigen Tests (GENB-COVAG025-NU-1) *CLIA Certificate Required*

GenBody COVID-19 Rapid Antigen Tests (GENB-COVAG025-NU-1) *CLIA Certificate Required*

$160.00 USD
$160.00 USD
Sale Sold out

⚠️ Back Order Estimated Restock Date:

Order Packaging

1 Kit (25 Tests/Kit) Includes Controls

Vendor Shipping & Returns

**CLIA Certificate Required for purchase**

CLIAwaived, Inc. Shipping Policy:
$10.95 Shipping. Free shipping on 10 or more CliaWaived Inc products, GND (1-5 BUS DAYS) in continental USA. Exclusions may apply.

CLIAwaived, Inc. Return Policy:
20% restocking fee, 10% administration fee. Shipping is paid for by the customer. Original packaging. No returns after 10 days.
No Cancellations; No Returns on PPE or PPE-related products; All Sales Final. Not all products are eligible for returns. Exclusions may apply.

All returns must be approved by our Returns Department. An e-mail notification will be issued regarding your return status and return instructions, should this apply. Any product returned for credit without an authorized RMA number clearly printed on the outside package or shipping label will be refused. Unauthorized returns will not be honored or accepted for credit.

View full details

GenBody COVID-19 Rapid Antigen Tests, (25 Tests per Kit, Includes Controls)

**Required CLIA Certificate for purchase**

The Genbody COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens. Rapid detection of SARS-CoV-2 will play a key role in the global spread of the virus.  An affordable and sensitive test this test does not require an additional reader and has a processing time of 15-20 minutes. Collection tube is pre-filled for convenience.

  • Time to results in 15-20 mins
  • Collection Method: Anterior Nasal
  • For use under an Emergency Use Authorization (EUA) Only
  • For in vitro diagnostic use only
  • For professional use only

  • Letter of Authorization

    "The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner "